Rapid COVID-19 Response Veredus Laboratories demonstrated agility in developing and launching SARS-CoV-2 diagnostic solutions swiftly during the pandemic, indicating their capacity to support ongoing demand for innovative molecular tests in emerging health crises.

Portable Diagnostic Devices The company's focus on portable lab-on-chip diagnostic tools offers opportunities to expand into markets requiring point-of-care testing, especially in remote or resource-limited settings where portability and quick results are highly valued.

Regulatory Compliance With ISO 9001 and ISO 13485 certifications, Veredus ensures high-quality manufacturing standards, making their products attractive to health systems seeking reliable and compliant molecular diagnostic solutions.

Expanding Test Portfolio Recent launches of SARS-CoV, COVID-19 tests, and extraction-free RT-PCR kits position Veredus as a comprehensive provider of molecular testing solutions, opening avenues to serve laboratories, clinics, and government health agencies.

Market Expansion Potential Given their strategic location in Singapore and successful product deployment for global health issues, Veredus can leverage their technological expertise to penetrate new geographical markets with emerging infectious disease testing needs.